본문 바로가기
주메뉴 바로가기
온라인 견적문의
바로가기
취급 브랜드
취급 브랜드
제품소개
HOT / NEW
Antibody / Antigen
Biosimilar
Blood / Plasma / PBMC / Serum
Cell line / Culture / Media
Chemical / Peptide / Reagent
Consumable / Instrument
ELISA / Assay Kit
Glyco- / Nano- / Chromato-
Mycoplasma / Contamination
PCR
Protein
Standards
Virus / Pseudovirus
합성서비스
학술정보
Protocol
학술문의
카탈로그
이벤트
이벤트
고객지원
견적문의
공지사항
주문 가이드
회사소개
인사말
연혁
Contact
메뉴
HOME
제품소개
Home
취급브랜드
제품소개
학술정보
이벤트
고객지원
회사소개
HOT / NEW
Antibody / Antigen
Biosimilar
Blood / Plasma / PBMC / Serum
Cell line / Culture / Media
Chemical / Peptide / Reagent
Consumable / Instrument
ELISA / Assay Kit
Glyco- / Nano- / Chromato-
Mycoplasma / Contamination
PCR
Protein
Standards
Virus / Pseudovirus
합성서비스
제품리스트
AntibodySystem
Ichor Bio
Proteogenix
전체 : 428
[Antibodysystem] Research Grade Tremelimumab
DHD17203
[Antibodysystem] Research Grade Pacmilimab
DHJ70105
[Antiobodysystem] Research Grade Catumaxomab
DHD17406
[Antibodysystem] Research Grade Modotuximab
DHB86904
[Proteogenix] Anti-CD28 Biosimilar – Anti-CD28(Tp44) mAb – Research Grade
PX-TA1625
[Antibodysystem] Research Grade Tomuzotuximab
DHB86905
[Antibodysystem] Research Grade Solanezumab
DHC12505
[Antibodysystem] Research Grade Bapineuzumab
DHC12507
[Antibodysystem] Research Grade Semorinemab
DHC82404
[Antibodysystem] Research Grade Bepranemab
DHC82405
[Antibodysystem] Research Grade Cinpanemab
DHE22001
[Proteogenix] Anti-CLDN18.2 Biosimilar – Anti-Claudin18.2 mAb – Research Grade
PX-TA1624
처음페이지
이전페이지
21
22
23
24
25
26
27
28
29
30
다음페이지
마지막페이지
카톡문의
견적문의
이벤트
공지사항
인스타그램
![[Antibodysystem] Research Grade Tremelimumab](/uploaded/product/797/large_439e0bb3d6921db2d36d550e901c4ffb0.jpg)
![[Antibodysystem] Research Grade Pacmilimab](/uploaded/product/796/large_6e006913be6464d2bb824a1813cdcefa0.jpg)
![[Antiobodysystem] Research Grade Catumaxomab](/uploaded/product/795/large_76fc7d6623d7c7cb8e6e5396b6cdb4140.png)
![[Antibodysystem] Research Grade Modotuximab](/uploaded/product/794/large_b8095fc64e9508e33f9d2609215021510.jpg)
![[Proteogenix] Anti-CD28 Biosimilar – Anti-CD28(Tp44) mAb – Research Grade](/uploaded/product/793/large_74f0f797d1b1f8b15fcfe6ae39a770b10.png)
![[Antibodysystem] Research Grade Tomuzotuximab](/uploaded/product/783/large_e6eaf9cf5245ccca11a22f8e35c5f80f0.jpg)
![[Antibodysystem] Research Grade Solanezumab](/uploaded/product/782/large_46a2b85283268ef5a8097446ed72f3310.jpg)
![[Antibodysystem] Research Grade Bapineuzumab](/uploaded/product/781/large_0c739c5cdc5427d31b68da3963c41eb10.jpg)
![[Antibodysystem] Research Grade Semorinemab](/uploaded/product/780/large_189acc4a484d6f699dff451c382561ac0.jpg)
![[Antibodysystem] Research Grade Bepranemab](/uploaded/product/779/large_1747159a2352fdf06142fae2c79af6210.jpg)
![[Antibodysystem] Research Grade Cinpanemab](/uploaded/product/778/large_b1d298b602e0b2b969cffa9c0a005df30.jpg)
![[Proteogenix] Anti-CLDN18.2 Biosimilar – Anti-Claudin18.2 mAb – Research Grade](/uploaded/product/762/large_6da6174335218fb3b56ef21e27b60cc70.png)
